Healthtech funding in Q3 2023
European Healthtech startup funding raised during Q3 2023.
In Q3 2023, 103 European Healthtech companies closed 105 funding rounds and raised €3.7B in equity funding (excluding debt and grants), up 111.0% versus Q3 2022. Debt rounds added €6.0M. Netherlands led by capital raised, and Bpifrance was the most active investor. Data as of 20 Nov 2026.
Equity funding
€3.7B
+111.0% vs Q3 2022 · excl. debt & grants · +€6.0M debt
Funding rounds
105
-27.6% vs Q3 2022
Companies
103
Top country
Netherlands
Rank among sectors
#4
13.1% of sector funding
Debt financing
€6.0M
0.2% of total
Top-10 round share
88.3%
of disclosed capital
Rounds ≥ €100M
3
Funding by month
€ raised vs rounds, by monthHealthtech — funding by month, Q3 2023 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Jul | €279M | 36 |
| Aug | €3.0B | 30 |
| Sep | €391M | 39 |
Top countries
by € raisedHealthtech — top countries by capital, Q3 2023 — interactive chart.
Data table
| Healthtech — top countries by capital, Q3 2023 | |
|---|---|
| Netherlands | €2.6B |
| UK | €692M |
| Denmark | €109M |
| Sweden | €74M |
| France | €61M |
| Switzerland | €50M |
| Germany | €43M |
| Spain | €21M |
Stage mix
by € raisedHealthtech — stage mix, Q3 2023 — interactive chart.
Data table
| Healthtech — stage mix, Q3 2023 | |
|---|---|
| Other | €3.3B |
| Series A | €226M |
| Series B | €175M |
| Seed | €36M |
| Debt | €6.0M |
| Grant | €5.9M |
| Pre-Seed | €5.1M |
| Series D+ | €716k |
Top deals
largest disclosed rounds in Q3 2023| Company | Stage | Date | Amount |
|---|---|---|---|
| Philips | Other | Aug 2023 | €2.6B |
| Compass Pathways | Other | Aug 2023 | €261M |
| CMR Surgical | Other | Sep 2023 | €154M |
| Neko Health | Series A | Jul 2023 | €60M |
| Corti | Series B | Sep 2023 | €56M |
| Causaly | Series B | Jul 2023 | €54M |
| Lightcast Discovery | Series B | Aug 2023 | €45M |
| MYCB1 | Other | Sep 2023 | €31M |
| Bactolife | Series A | Aug 2023 | €30M |
| Organox | Other | Jul 2023 | €29M |
| GenePlanet | Other | Jul 2023 | €20M |
| Genomes.io | Other | Aug 2023 | €18M |
| Entia | Series A | Jul 2023 | €18M |
| Lindus Health | Series A | Aug 2023 | €16M |
| Clinomic | Other | Aug 2023 | €16M |
Top investors
most active in Q3 2023, by deal count- Bpifrance3 deals
- Octopus Ventures3 deals
- +ND Capital2 deals
- Atomico2 deals
- BGF2 deals
- Bio & Tech Smart Capital FCRE2 deals
- Calm Storm Ventures2 deals
- CDTI2 deals
- Cottonwood Technology Fund2 deals
- EIT Health2 deals